体外诊断成分股数据 申万3级
851534.SI (39)
数据更新时间：2025-09-26
"-"表示无或者负数
| 序号 | 股票代码 | 股票简称 | 纳入时间 | 申万1级 | 申万2级 | 申万3级 | 价格
|
市盈率
|
市盈率ttm
|
市净率
|
股息率
|
市值（亿元）
|
归母净利润同比增长(06-30)
|
归母净利润同比增长(03-31)
|
营业收入同比增长(06-30)
|
营业收入同比增长(03-31)
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 002932.SZ | 明德生物 | 2018-07-17 | — | — | 体外诊断 | 18.81 | 58.69 | 200.13 | 0.79 | 6.17% | 43.74 | -80.82% | -111.43% | -9.71% | 14.76% |
| 2 | 688389.SH | 普门科技 | 2023-09-25 | — | — | 体外诊断 | 13.73 | 17.03 | 19.94 | 2.86 | — | 58.83 | -29.27% | -49.93% | -14.08% | -29.70% |
| 3 | 002086.SZ | 东方海洋 | 2024-01-02 | — | — | 体外诊断 | 2.59 | — | — | 3.73 | — | 50.74 | -71.23% | -53.58% | 0.34% | 12.95% |
| 4 | 300439.SZ | 美康生物 | 2015-04-29 | — | — | 体外诊断 | 10.26 | 15.28 | 28.92 | 1.34 | 1.31% | 39.43 | -68.15% | -61.57% | -22.43% | -22.32% |
| 5 | 002030.SZ | 达安基因 | 2004-08-16 | — | — | 体外诊断 | 6.28 | — | — | 1.14 | — | 88.14 | 54.37% | 114.57% | -15.44% | -14.71% |
| 6 | 688253.SH | 英诺特 | 2023-09-25 | — | — | 体外诊断 | 31.12 | 17.27 | 25.73 | 2.11 | — | 42.63 | -39.36% | -34.77% | -34.35% | -26.51% |
| 7 | 300642.SZ | 透景生命 | 2017-04-28 | — | — | 体外诊断 | 21.92 | 103.18 | 116.22 | 2.4 | 0.68% | 35.63 | -58.41% | 110.51% | -26.25% | -19.53% |
| 8 | 600645.SH | 中源协和 | 1999-12-30 | — | — | 体外诊断 | 23.8 | 110.98 | 152.69 | 3.05 | — | 111.37 | -32.18% | -30.18% | -10.71% | -11.86% |
| 9 | 688606.SH | 奥泰生物 | 2023-09-25 | — | — | 体外诊断 | 67.3 | 17.64 | 17.18 | 1.37 | — | 53.36 | 6.57% | 36.68% | 8.41% | 4.28% |
| 10 | 688217.SH | 睿昂基因 | 2023-09-25 | — | — | 体外诊断 | 27.71 | — | — | 1.7 | — | 15.48 | -61.46% | 529.26% | -22.29% | -14.72% |
| 11 | 688068.SH | 热景生物 | 2023-09-25 | — | — | 体外诊断 | 169.0 | — | — | 5.33 | — | 156.68 | -93.24% | -574.96% | -18.04% | -19.71% |
| 12 | 300942.SZ | 易瑞生物 | 2021-02-23 | — | — | 体外诊断 | 10.43 | 246.83 | 201.04 | 5.09 | 0.17% | 42.25 | 250.02% | 52.95% | 5.44% | 35.28% |
| 13 | 002022.SZ | 科华生物 | 2004-07-28 | — | — | 体外诊断 | 6.34 | — | — | 1.02 | — | 32.61 | -154.37% | -84.79% | -12.65% | -12.50% |
| 14 | 688298.SH | 东方生物 | 2023-09-25 | — | — | 体外诊断 | 25.53 | — | — | 0.8 | — | 51.47 | -7.58% | -71.41% | -3.62% | 4.94% |
| 15 | 688399.SH | 硕世生物 | 2023-09-25 | — | — | 体外诊断 | 63.34 | — | — | 1.79 | — | 53.12 | -86.35% | -68.01% | -1.05% | 0.54% |
| 16 | 688575.SH | 亚辉龙 | 2023-09-25 | — | — | 体外诊断 | 14.3 | 27.05 | 52.7 | 3.06 | — | 81.57 | -84.82% | -84.63% | -15.79% | -3.13% |
| 17 | 688393.SH | 安必平 | 2023-09-25 | — | — | 体外诊断 | 26.3 | 115.58 | — | 2.0 | — | 24.61 | -176.38% | -238.49% | -30.11% | -28.51% |
| 18 | 688468.SH | 科美诊断 | 2023-09-25 | — | — | 体外诊断 | 7.62 | 24.05 | 40.88 | 2.2 | — | 30.56 | -68.24% | -62.12% | -27.03% | -27.01% |
| 19 | 688338.SH | 赛科希德 | 2023-09-25 | — | — | 体外诊断 | 26.2 | 24.61 | 28.3 | 1.69 | — | 27.81 | -23.47% | -23.98% | -12.62% | -9.47% |
| 20 | 688317.SH | 之江生物 | 2023-09-25 | — | — | 体外诊断 | 22.7 | — | — | 1.27 | — | 43.62 | -137.88% | -159.53% | -36.91% | -37.27% |
| 21 | 688067.SH | 爱威科技 | 2023-09-25 | — | — | 体外诊断 | 25.2 | 75.02 | 67.74 | 3.41 | — | 17.14 | 21.16% | 24.63% | 12.70% | 13.85% |
| 22 | 300463.SZ | 迈克生物 | 2015-06-04 | — | — | 体外诊断 | 11.57 | 55.17 | — | 1.12 | 0.9% | 69.96 | -83.12% | -80.09% | -15.94% | -17.22% |
| 23 | 688426.SH | 康为世纪 | 2024-07-31 | — | — | 体外诊断 | 26.9 | — | — | 2.15 | — | 30.26 | -11.70% | 21.49% | 29.74% | 49.31% |
| 24 | 688193.SH | 仁度生物 | 2023-09-25 | — | — | 体外诊断 | 46.77 | — | — | 2.05 | — | 18.74 | -52.94% | -67.04% | -6.27% | -9.22% |
| 25 | 300832.SZ | 新产业 | 2020-05-19 | — | — | 体外诊断 | 68.32 | 29.36 | 31.64 | 6.46 | 1.9% | 536.80 | -14.62% | 2.65% | -1.18% | 10.12% |
| 26 | 300685.SZ | 艾德生物 | 2017-08-09 | — | — | 体外诊断 | 22.46 | 34.5 | 29.31 | 4.66 | 1.34% | 87.94 | 31.41% | 40.92% | 6.69% | 16.63% |
| 27 | 300396.SZ | 迪瑞医疗 | 2014-09-17 | — | — | 体外诊断 | 14.07 | 27.04 | — | 1.96 | 1.85% | 38.37 | -117.13% | -87.13% | -60.07% | -72.47% |
| 28 | 300406.SZ | 九强生物 | 2014-11-06 | — | — | 体外诊断 | 13.38 | 14.73 | 17.15 | 2.12 | 5.21% | 78.45 | -30.01% | -30.99% | -18.67% | -18.81% |
| 29 | 603387.SH | 基蛋生物 | 2017-07-24 | — | — | 体外诊断 | 8.0 | 18.14 | 21.86 | 1.54 | 2.25% | 40.57 | -25.88% | -25.24% | -17.00% | -24.08% |
| 30 | 002432.SZ | 九安医疗 | 2022-08-01 | — | — | 体外诊断 | 38.54 | 10.96 | 9.2 | 0.84 | 0.47% | 182.90 | 52.91% | 7.62% | -43.35% | -33.49% |
| 31 | 300289.SZ | 利德曼 | 2012-02-23 | — | — | 体外诊断 | 7.5 | — | — | 2.46 | — | 40.80 | -800.43% | 53.73% | -14.80% | -16.61% |
| 32 | 603658.SH | 安图生物 | 2016-09-08 | — | — | 体外诊断 | 39.36 | 18.83 | 19.63 | 2.66 | 3.2% | 224.91 | -7.83% | -16.76% | -6.65% | -8.56% |
| 33 | 300482.SZ | 万孚生物 | 2015-07-07 | — | — | 体外诊断 | 21.23 | 17.69 | 25.16 | 1.88 | 1.94% | 99.37 | -46.82% | -13.37% | -20.92% | -7.06% |
| 34 | 688289.SH | 圣湘生物 | 2023-09-25 | — | — | 体外诊断 | 20.5 | 43.1 | 42.18 | 1.67 | — | 118.77 | 3.84% | 13.22% | 21.15% | 21.62% |
| 35 | 300639.SZ | 凯普生物 | 2017-04-19 | — | — | 体外诊断 | 5.62 | — | — | 0.93 | — | 36.33 | -16.46% | -90.21% | -22.96% | -26.78% |
| 36 | 600807.SH | 济高发展 | 2024-07-31 | — | — | 体外诊断 | 3.02 | — | — | 39.75 | — | 26.72 | -57.51% | -48.99% | -23.36% | 57.81% |
| 37 | 688656.SH | 浩欧博 | 2023-09-25 | — | — | 体外诊断 | 150.57 | 259.71 | 329.68 | 11.74 | — | 95.58 | -39.10% | -56.97% | -6.48% | -9.33% |
| 38 | 688767.SH | 博拓生物 | 2023-09-25 | — | — | 体外诊断 | 39.75 | 35.02 | 54.09 | 2.56 | — | 59.36 | -82.82% | -77.97% | -23.91% | -35.20% |
| 39 | 688075.SH | 安旭生物 | 2023-09-25 | — | — | 体外诊断 | 38.15 | 25.21 | 35.57 | 0.94 | — | 48.48 | -48.57% | -51.52% | -7.42% | -10.90% |
免责声明：数据相关栏目所收集数据，均来自第三方个人或企业公开数据以及国家统计网站公开发布数据，数据由计算机技术自动收集更新再由作者校验，作者将尽力校验，但不能保证数据的完全准确。 阅读本栏目的用户必须明白，图表所示结果或标示仅供学习参考使用，均不构成交易依据。任何据此进行交易等行为，而引致的任何损害后果，本站概不负责。
关注微信公众号
获取更多数据
获取更多数据
关闭 X